Posted on 26 December 2013.
China Bans Shenzhen Hepatitis B Vaccine following 4 Infant Deaths
Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company. The circular, jointly issued by the China Food and Drug Administration (CFDA) and the National …
Read more on CRIENGLISH.com